About Nucrest
Nucrest is a Healthcare company based in Mumbai (India). Distributes high-quality pharmaceutical products to healthcare providers. It operates on a B2B model. Its Indian entity Nucrest Pharma Private Limited reported revenue of ₹71.97 Cr. Its focus areas include Pharmaceuticals, Distribution and Product Supply. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Nucrest distributes high-quality pharmaceutical products to healthcare providers through providing healthcare solutions, producing pharmaceutical products, distribution, and product supply. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website nucrest.in
- Legal Name Nucrest Pharma Private Limited
- Date of Incorporation 09 Dec, 2019
- Jurisdiction New Link Road Borivali, Maharashtra, India
- Annual Revenue₹71.97 Cr
FY 2025 · +21% YoY
- Net Profit₹4.74 Cr
FY 2025 · 7% margin
- EBITDA₹6.75 Cr
FY 2025 · 9% margin
Associated legal entities of Nucrest
Nucrest operates through Nucrest Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nucrest Pharma Private Limited CIN U24110MH2019PTC334133 | Active | 09 Dec 2019 | Mumbai, Maharashtra | ₹72.0 Cr | 2 | View details |
Board of directors of Nucrest Pharma Private Limited (Nucrest)
Nucrest Pharma Private Limited is the primary company behind Nucrest. The board of Nucrest Pharma Private Limited currently have 2 directors; the longest-serving is Ashok Rupchand Panjwani, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashok Rupchand Panjwani DIN 00928254 | Director | 09 Dec 2019 | 6 yrs 10 mo | Nucrest Pharma Private Limited |
| Vikram Ashok Panjwani DIN 08632793 | Director | 09 Dec 2019 | 6 yrs 10 mo | Nucrest Pharma Private Limited |
Financials of Nucrest
Figures of Nucrest Pharma Private Limited, the primary company behind Nucrest, for FY 2025. Revenue was ₹71.97 Cr (+21% year on year). Net profit was ₹4.74 Cr (7% margin). EBITDA was ₹6.75 Cr (9% margin). Revenue has grown at a compounded annual rate of -5% over three years.
- ₹71.97 CrRevenue · FY 2025 · +21% YoY
- ₹4.74 CrNet profit · 7% margin
- ₹6.75 CrEBITDA · 9% margin
- ₹1.00 CrPaid-up capital
- -5%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Nucrest Pharma Private Limited are on its company page.
Detailed financial statements for Nucrest
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Nucrest
Nucrest has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Nucrest
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nucrest
Nucrest is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Nucrest, Nucrest Pharma Private Limited, reported revenue of ₹71.97 Cr for FY 2025, up 21% year on year.
Nucrest distributes high-quality pharmaceutical products to healthcare providers through providing healthcare solutions, producing pharmaceutical products, distribution, and product supply. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Nucrest's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Nucrest operates through Nucrest Pharma Private Limited.
The legal entities of Nucrest currently have 2 directors, including Ashok Rupchand Panjwani, Vikram Ashok Panjwani.